Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer.
2020
Michael W Kattan, and Ronald M Bukowski
Department of Quantitative Health Sciences in the Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Michael W Kattan, and Ronald M Bukowski
Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.
August 2016, International journal of urology : official journal of the Japanese Urological Association,
Michael W Kattan, and Ronald M Bukowski
Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
January 2020, Frontiers in oncology,
Michael W Kattan, and Ronald M Bukowski
Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
July 2018, European urology focus,
Michael W Kattan, and Ronald M Bukowski
Editorial Comment to Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.
August 2016, International journal of urology : official journal of the Japanese Urological Association,
Michael W Kattan, and Ronald M Bukowski
The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis.
January 2020, Frontiers in oncology,
Michael W Kattan, and Ronald M Bukowski
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
January 2019, The Journal of clinical investigation,
Michael W Kattan, and Ronald M Bukowski
Current status of circulating tumor cell androgen receptor splice variant-7 in metastatic castration-resistant prostate cancer.
December 2019, Annals of translational medicine,
Michael W Kattan, and Ronald M Bukowski
PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells.
January 2021, International journal of biological sciences,
Michael W Kattan, and Ronald M Bukowski
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
August 2015, JAMA oncology,
Michael W Kattan, and Ronald M Bukowski
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
November 2019, European urology,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name